The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years (structured market in 31 lots).
The specifications can be obtained in .pdf and .doc format and .xls on request to the Public Procurement Service addressed to
marches.info@chuliege.be with the words: "DDE CSCH - CHULG/23.206".
In case of possible discrepancy between the .pdf model and the other models, this is the first document
(model .pdf) which is authentic.
Clindamycin 300 mg (oral)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Ciprofloxacin 500 mg (oral)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Posaconazole 100 mg (oral)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Voriconazole 200 mg (oral)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Acyclovir 800 mg (oral permission)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Clarithromycin 500 mg (oral) (prolonged/modified release)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Amoxicillin 500 mg (oral) (dispersible tablet)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Flucloxacillin 1 g (injectable form)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Amoxicillin 1 g + Ac. Clavulanic 200 mg and Amoxicillin 2 g + Ac. Clavulanic 200 mg (injectable form)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Piperacilline 4 g + Tazobactam 500 mg (forme injectable)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Cefazolin 1 g and 2 g (form for injection)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Fluconazole 200 mg (oral)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Cefuroxime 750 mg and 1.5 g (form for injection)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Ceftazidime 1 g and 2 g (injectable form)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Meropenem 1 g (injectable form)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Clindamycin 600 mg/ 4ml (injectable form)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Linezolid 600 mg/300 ml (form for injection)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Vancomycin 500 mg and 1000 mg (injectable form)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Moxifloxacin 400 mg/250 ml (form for injection)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Ciprofloxacin 400 mg/200 ml (injectable form)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Caspofungin 50 mg + 70 mg (injectable form)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Voriconazole 200 mg (forme injectable)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Amoxicillin 875 mg + Ac. Clavulanic 125 mg (orally)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Foscarnet 6 g/250 ml (forme injectable)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Fluconazole 200 mg/100 ml (forme injectable)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Cefuroxime 500 mg (oral permission)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Minocycline 100 mg (oral)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Azithromycin 500 mg (oral)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Sulfamethoxazole 800 mg + trimethoprim 160 mg (oral)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Linezolid 600 mg (oral)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years
Moxifloxacin 400 mg (oral)The purpose of this contract is the conclusion of a framework agreement for the supply of anti-infective medicinal products for a period of 2 years renewable 1 time for a period of two years